Moderna's mRNA flu vaccine for older adults approved by FDA, ready for this flu season

Moderna has received FDA approval for the first mRNA-based influenza vaccine. The shot is tailored specifically for older adults and will be available for the upcoming flu season. It marks a significant milestone in flu prevention, extending mRNA technology beyond COVID-19 vaccines.